1. Home
  2. FBIO vs KPLT Comparison

FBIO vs KPLT Comparison

Compare FBIO & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • KPLT
  • Stock Information
  • Founded
  • FBIO 2006
  • KPLT 2012
  • Country
  • FBIO United States
  • KPLT United States
  • Employees
  • FBIO N/A
  • KPLT N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • KPLT Diversified Commercial Services
  • Sector
  • FBIO Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • FBIO Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • FBIO 39.4M
  • KPLT 33.2M
  • IPO Year
  • FBIO N/A
  • KPLT N/A
  • Fundamental
  • Price
  • FBIO $1.84
  • KPLT $6.37
  • Analyst Decision
  • FBIO Strong Buy
  • KPLT Hold
  • Analyst Count
  • FBIO 3
  • KPLT 2
  • Target Price
  • FBIO $18.00
  • KPLT $12.00
  • AVG Volume (30 Days)
  • FBIO 691.0K
  • KPLT 20.7K
  • Earning Date
  • FBIO 11-14-2024
  • KPLT 11-06-2024
  • Dividend Yield
  • FBIO N/A
  • KPLT N/A
  • EPS Growth
  • FBIO N/A
  • KPLT N/A
  • EPS
  • FBIO N/A
  • KPLT N/A
  • Revenue
  • FBIO $81,501,000.00
  • KPLT $241,789,000.00
  • Revenue This Year
  • FBIO N/A
  • KPLT $12.92
  • Revenue Next Year
  • FBIO $134.70
  • KPLT $6.30
  • P/E Ratio
  • FBIO N/A
  • KPLT N/A
  • Revenue Growth
  • FBIO 31.51
  • KPLT 14.99
  • 52 Week Low
  • FBIO $1.36
  • KPLT $5.79
  • 52 Week High
  • FBIO $4.43
  • KPLT $23.54
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 49.60
  • KPLT 37.93
  • Support Level
  • FBIO $1.78
  • KPLT $6.30
  • Resistance Level
  • FBIO $2.27
  • KPLT $6.91
  • Average True Range (ATR)
  • FBIO 0.17
  • KPLT 0.51
  • MACD
  • FBIO -0.03
  • KPLT 0.01
  • Stochastic Oscillator
  • FBIO 21.43
  • KPLT 0.00

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: